BA
The Boeing Company
BA has lower modeled downside risk, despite its lower overall score.
CVEO
Civeo Corporation
CVEO has a slight edge over BA overall on the model score.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CVEO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Stable |
CVEO's revenue and cash flow are currently healthy, and its profitability and balance sheet are stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
CVEO PE Valuation
CVEO has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over CVEO on the outlook, with more favorable profitability expectations.
CVEO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect CVEO's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over CVEO on earnings quality, reporting a profit while its opponent remains loss making.
CVEO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.65 | +$1.40 |
| Q2 2026 | -$1.19 | +$1.18 |
| Q1 2026 | -$1.21 | +$0.35 |
| Q4 2025 | -$1.59 | -$0.40 |
| Q3 2025 | -$2.05 | -250% |
| Q2 2025 | -$2.37 | -201% |
| Q1 2025 | -$1.56 | -175% |
| Q4 2024 | -$1.19 | -159% |
CVEO is still losing money, but far less than before: $0.65 per share over the past year, against $13.56 at its worst in early 2020.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over CVEO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CVEO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $193.1M | +13% |
| Q2 2026 | $180M | +11% |
| Q1 2026 | $172.7M | +20% |
| Q4 2025 | $161.6M | +7.1% |
| Q3 2025 | $170.5M | -3.3% |
| Q2 2025 | $162.7M | -14% |
| Q1 2025 | $144M | -13% |
| Q4 2024 | $151M | -12% |
CVEO's revenue has grown year over year for four quarters in a row: $193M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.9% | +2.8 points |
| Q2 2026 | 2.8% | +1.1 points |
| Q1 2026 | 1.8% | +5.6 points |
| Q4 2025 | -0.1% | +6.6 points |
| Q3 2025 | 4.1% | +4.1 points |
| Q2 2025 | 1.7% | -5.2 points |
| Q1 2025 | -3.8% | -2.8 points |
| Q4 2024 | -6.7% | -17 points |
CVEO has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CVEO on cash flow, with more consistent year-over-year improvement.
CVEO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21M | +156% |
| Q2 2026 | $7.9M | +$14.7M |
| Q1 2026 | -$13.9M | -$161K |
| Q4 2025 | $14.5M | +720% |
| Q3 2025 | $8.2M | -71% |
| Q2 2025 | -$6.8M | -125% |
| Q1 2025 | -$13.7M | -3787% |
| Q4 2024 | $1.8M | -94% |
CVEO's free cash flow has turned positive again: $30M over the past year, against −$11M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CVEO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5% | -551K shares |
| 1 year | -16% | -2M shares |
| 3 years | -30% | -4.5M shares |
| 5 years | -28% | -4M shares |
| Available history | -25% | -3.5M shares |
CVEO has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $22.3M |
| Q2 2026 | — |
| Q1 2026 | $14.4M |
| Q4 2025 | $4.9M |
| Q3 2025 | $26.2M |
| Q2 2025 | $19.1M |
| Q1 2025 | $3.3M |
| Q4 2024 | $5.6M |
CVEO spent $42M buying back its own shares over the past year, down 23% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CVEO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.3x | Moderate |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 2.8x | Moderate |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.6x | Very low |
CVEO has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CVEO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.6 | Neutral |
| Stochastic | 77.0 | Neutral |
CVEO's weekly RSI is 59 (neutral) and its Stochastic is 77 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
CVEO PE vs Industrials Sector
| Metric | CVEO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CVEO has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CVEO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.7 | 11% above |
| 20 week MA | $32.9 | 10% above |
| 50 week MA | $30.3 | 20% above |
| 100 week MA | $26.4 | 38% above |
| 200 week MA | $25.0 | 46% above |
CVEO has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CVEO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.2 | $15.1 | -6.7% |
| 2021 | $15.1 | $18.8 | +24% |
| 2022 | $18.8 | $31.5 | +67% |
| 2023 | $31.5 | $22.9 | -27% |
| 2024 | $22.9 | $22.2 | -2.8% |
| 2025 | $22.2 | $23.3 | +4.9% |
| 2026 YTD | $23.3 | $36.3 | +56% |
CVEO has the edge over BA on returns for 2026, with the stronger performance.